|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/10 | (2006.01) | ||
| A61K 47/10 | (2017.01) |
| (11) | Number of the document | 2364137 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09768284.3 |
| Date of filing the European patent application | 2009-12-03 | |
| (97) | Date of publication of the European application | 2011-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation | 2017-06-26 |
| (86) | Number | PCT/US2009/066570 |
| Date | 2009-12-03 |
| (87) | Number | WO 2010/065730 |
| Date | 2010-06-10 |
| (30) | Number | Date | Country code |
| 120081 P | 2008-12-05 | US |
| (72) |
KABRA, Bhagwati P., US
|
| (73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė suspensija |
| PHARMACEUTICAL SUSPENSION |
| Payment date | Validity (years) | Amount | |
| 2017-11-29 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-12-03 |